![]() |
|
#1
|
|||
|
|||
|
* results from 10-week analysis of phase 2 study with filgotinib in Crohn's disease presented at ECCO Source text for Eikon: Further company coverage: (Gdynia Newsroom) ![]() ??????? ??????: BRIEF-Galapagos presents filgotinib results at ECCO || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|